Kari Brown

Kari Brown

Company: Aimmune Therapeutics

Job title: Senior Medical Director


Choosing Appropriate Functional as Well as Translational Disease Models to Gain Better Understanding of the Disease Pathophysiology 9:15 am

The journey from animal/cell models to humans Understanding the molecular mechanisms responsible for allergies Determining the intended use of the assay/biomarker development and how to incorporate that into disease planningRead more

day: Day Two

Panel Discussion: Recognizing Novel & Emerging Biomarkers of Significance to Help Identify Populations for Clinical Trial Studies, Monitor Therapeutic Response & Identify Side Effects 4:00 pm

How do we reduce the need for DBPCFC (double-blind placebo-controlled food challenge) for clinical assessment? Developing biomarkers that are informative of key clinical parameters of food allergy, including threshold of reactivity, risk of severe reactions, probability of natural resolution, and probability of successful treatment response to immunotherapy How do we bring about the shift to…Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.